Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Dyslipidemia

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 59 articles:
HTML format



Single Articles


    June 2020
  1. KHERA AV, Hegele RA
    What Is Familial Hypercholesterolemia, and Why Does It Matter?
    Circulation. 2020;141:1760-1763.
    PubMed    


  2. HOVINGH GK, Lepor NE, Kallend D, Stoekenbroek RM, et al
    Inclisiran Durably Lowers Low-Density Lipoprotein Cholesterol and Proprotein Convertase Subtilisin/Kexin Type 9 Expression in Homozygous Familial Hypercholesterolemia: The ORION-2 Pilot Study.
    Circulation. 2020;141:1829-1831.
    PubMed    


    May 2020
  3. HU P, Dharmayat KI, Stevens CAT, Sharabiani MTA, et al
    Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis.
    Circulation. 2020 May 29. doi: 10.1161/CIRCULATIONAHA.119.044795.
    PubMed    


    April 2020
  4. STONE NJ, Blumenthal RS, Lloyd-Jones D, Grundy SM, et al
    Comparing Primary Prevention Recommendations: A Focused Look at United States and European Guidelines on Dyslipidemia.
    Circulation. 2020;141:1117-1120.
    PubMed    


  5. VIRANI SS, Smith SC Jr, Stone NJ, Grundy SM, et al
    Secondary Prevention for Atherosclerotic Cardiovascular Disease: Comparing Recent US and European Guidelines on Dyslipidemia.
    Circulation. 2020;141:1121-1123.
    PubMed    


  6. FRIED JA, Ramasubbu K, Bhatt R, Topkara VK, et al
    The Variety of Cardiovascular Presentations of COVID-19.
    Circulation. 2020 Apr 3. doi: 10.1161/CIRCULATIONAHA.120.047164.
    PubMed    


    November 2019
  7. JUKEMA JW, Zijlstra LE, Bhatt DL, Bittner VA, et al
    Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.043826.
    PubMed    


  8. DAMASK A, Steg PG, Schwartz GG, Szarek M, et al
    Patients with High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit from Alirocumab Treatment in the Odyssey Outcomes Trial.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044434.
    PubMed     Abstract available


    September 2019
  9. ROE MT, Li QH, Bhatt DL, Bittner VA, et al
    Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.
    Circulation. 2019 Sep 2. doi: 10.1161/CIRCULATIONAHA.119.042551.
    PubMed    


    August 2019
  10. SKULAS-RAY AC, Wilson PWF, Harris WS, Brinton EA, et al
    Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Circulation. 2019 Aug 19:CIR0000000000000709. doi: 10.1161/CIR.0000000000000709.
    PubMed     Abstract available


    June 2019
  11. AHMAD Z, Banerjee P, Hamon S, Chan KC, et al
    Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia.
    Circulation. 2019 Jun 27. doi: 10.1161/CIRCULATIONAHA.118.039107.
    PubMed     Abstract available


  12. WILSON PWF, Polonsky TS, Miedema MD, Khera A, et al
    Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelin
    Circulation. 2019;139:e1144-e1161.
    PubMed     Abstract available


  13. GRUNDY SM, Stone NJ, Bailey AL, Beam C, et al
    2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2019;139:e1082-e1143.
    PubMed    


  14. KHERA A
    The New 2018 Cholesterol Guidelines.
    Circulation. 2019;139:2805-2808.
    PubMed    


  15. GRUNDY SM, Stone NJ, Bailey AL, Beam C, et al
    2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2019;139:e1046-e1081.
    PubMed    


    May 2019
  16. STEG PG, Szarek M, Bhatt DL, Bittner VA, et al
    Effect of Alirocumab on Mortality After Acute Coronary Syndromes: An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial.
    Circulation. 2019 May 23. doi: 10.1161/CIRCULATIONAHA.118.038840.
    PubMed     Abstract available


    April 2019
  17. TZIAKAS DN, Chalikias G, Pavlaki M, Kareli D, et al
    Lysed Erythrocyte Membranes Promote Vascular Calcification.
    Circulation. 2019;139:2032-2048.
    PubMed     Abstract available


  18. WRIGHT AK, Kontopantelis E, Emsley R, Buchan IE, et al
    Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes: A Population-Based Cohort Study Assessing Sex Disparities.
    Circulation. 2019 Apr 15. doi: 10.1161/CIRCULATIONAHA.118.039100.
    PubMed     Abstract available


    March 2019
  19. ARNETT DK, Blumenthal RS, Albert MA, Buroker AB, et al
    2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease.
    Circulation. 2019 Mar 17:CIR0000000000000678. doi: 10.1161/CIR.0000000000000678.
    PubMed    


  20. ARNETT DK, Blumenthal RS, Albert MA, Buroker AB, et al
    2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary.
    Circulation. 2019 Mar 17:CIR0000000000000677. doi: 10.1161/CIR.0000000000000677.
    PubMed    


    February 2019
  21. PETERS SAE, Muntner P, Woodward M
    Sex Differences in the Prevalence of, and Trends in, Cardiovascular Risk Factors, Treatment, and Control in the United States, 2001 to 2016.
    Circulation. 2019;139:1025-1035.
    PubMed     Abstract available


    December 2018
  22. KIM MK, Han K, Park YM, Kwon HS, et al
    Associations of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Mass Index With Mortality and Cardiovascular Outcomes in the General Population.
    Circulation. 2018;138:2627-2637.
    PubMed     Abstract available


    November 2018
  23. KHERA AV, Chaffin M, Zekavat SM, Collins RL, et al
    Whole Genome Sequencing to Characterize Monogenic and Polygenic Contributions in Patients Hospitalized with Early-Onset Myocardial Infarction.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.035658.
    PubMed     Abstract available


    May 2018
  24. XIANG R, Fan LL, Huang H, Chen YQ, et al
    Increased RTN3 Leads to Obesity and Hypertriglyceridemia by Interacting with HSPA5.
    Circulation. 2018 May 1. pii: CIRCULATIONAHA.117.030718.
    PubMed     Abstract available


    March 2018
  25. BEHESHTI S, Madsen CM, Varbo A, Benn M, et al
    Relationship of Familial Hypercholesterolemia and High LDL Cholesterol to Ischemic Stroke: The Copenhagen General Population Study.
    Circulation. 2018 Mar 28. pii: CIRCULATIONAHA.118.033470.
    PubMed     Abstract available


  26. NEELAND IJ, Poirier P, Despres JP
    Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management.
    Circulation. 2018;137:1391-1406.
    PubMed     Abstract available


  27. BUCHOLZ EM, Rodday AM, Kolor K, Khoury MJ, et al
    Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999-2014).
    Circulation. 2018 Mar 26. pii: CIRCULATIONAHA.117.032321.
    PubMed     Abstract available


  28. TURER CB, Brady TM, de Ferranti SD
    Obesity, Hypertension, and Dyslipidemia in Childhood Are Key Modifiable Antecedents of Adult Cardiovascular Disease: A Call to Action.
    Circulation. 2018;137:1256-1259.
    PubMed    


  29. NADRUZ W JR, Claggett B, Henglin M, Shah AM, et al
    Widening Racial Differences in Risks for Coronary Heart Disease.
    Circulation. 2018;137:1195-1197.
    PubMed    


    February 2018
  30. BALDER JW, Rimbert A, Zhang X, Viel M, et al
    Genetics, Lifestyle, and Low-Density Lipoprotein Cholesterol in Young and Apparently Healthy Women.
    Circulation. 2018;137:820-831.
    PubMed     Abstract available


  31. KUSTERS DM, Braamskamp MJAM, Langslet G, McCrindle BW, et al
    Response by Kusters et al to Letter Regarding Article, "Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Ros
    Circulation. 2018;137:641-642.
    PubMed    


  32. KOH KK
    Letter by Koh Regarding Article, "Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)"
    Circulation. 2018;137:639-640.
    PubMed    


    December 2017
  33. HESS GP, Natarajan P, Faridi KF, Fievitz A, et al
    Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy: Payer Approvals and Rejections, and Patient Characteristics for Successful Prescribing.
    Circulation. 2017;136:2210-2219.
    PubMed     Abstract available


    November 2017
  34. GEPNER Y, Shelef I, Schwarzfuchs D, Zelicha H, et al
    Effect of Distinct Lifestyle Interventions on Mobilization of Fat Storage Pools: The CENTRAL MRI Randomized Controlled Trial.
    Circulation. 2017 Nov 15. pii: CIRCULATIONAHA.117.030501.
    PubMed     Abstract available


  35. PEREZ DE ISLA L, Saltijeral Cerezo A, Mata P
    Response by Perez de Isla et al to Letter Regarding Article, "Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study)".
    Circulation. 2017;136:1984.
    PubMed    


  36. NATALE F, Di Maio M, Calabro P
    Letter by Natale et al Regarding Article, "Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study)".
    Circulation. 2017;136:1982-1983.
    PubMed    


    October 2017
  37. GAUDINO M, Antoniades C, Benedetto U, Deb S, et al
    Mechanisms, Consequences, and Prevention of Coronary Graft Failure.
    Circulation. 2017;136:1749-1764.
    PubMed     Abstract available


    September 2017
  38. VALLEJO-VAZ AJ, Robertson M, Catapano AL, Watts GF, et al
    LDL-Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men with Primary Elevations of LDL-Cholesterol Levels of 190 mg/dL or Above: Analyses from the WOSCOPS 5-year Randomised Trial and 20-year Observational Follow-Up.
    Circulation. 2017 Sep 6. pii: CIRCULATIONAHA.117.027966.
    PubMed     Abstract available


    August 2017
  39. DROUIN-CHARTIER JP, Tremblay AJ, Bergeron J, Lamarche B, et al
    The Low-Density Lipoprotein Receptor Genotype Is a Significant Determinant of the Rebound in Low-Density Lipoprotein Cholesterol Concentration After Lipoprotein Apheresis Among Patients With Homozygous Familial Hypercholesterolemia.
    Circulation. 2017;136:880-882.
    PubMed    


    July 2017
  40. LERMAN JB, Joshi AA, Chaturvedi A, Aberra TM, et al
    Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study.
    Circulation. 2017;136:263-276.
    PubMed     Abstract available


  41. BLOM DJ, Averna MR, Meagher EA, du Toit Theron H, et al
    Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia.
    Circulation. 2017;136:332-335.
    PubMed    


    June 2017
  42. BRAAMSKAMP MJAM, Langslet G, McCrindle BW, Cassiman DM, et al
    Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children with Heterozygous Familial Hypercholesterolemia: The CHARON Study.
    Circulation. 2017 Jun 7. pii: CIRCULATIONAHA.116.025158.
    PubMed     Abstract available


    March 2017
  43. PEREZ DE ISLA L, Alonso R, Mata N, Fernandez-Perez C, et al
    Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry.
    Circulation. 2017 Mar 8. pii: CIRCULATIONAHA.116.024541.
    PubMed     Abstract available


    November 2016
  44. LI P, Yin YL, Guo T, Sun XY, et al
    Inhibition of Aberrant MicroRNA-133a Expression in Endothelial Cells by Statin Prevents Endothelial Dysfunction by Targeting GTP Cyclohydrolase 1 in Vivo.
    Circulation. 2016;134:1752-1765.
    PubMed     Abstract available


  45. SAITO Y, Okada S, Ogawa H, Soejima H, et al
    Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes: 10-year Follow-up of a Randomized Controlled Trial.
    Circulation. 2016 Nov 15. pii: CIRCULATIONAHA.116.025760.
    PubMed     Abstract available


  46. MAHMOODI BK, Cushman M, Naess IA, Allison MA, et al
    Association of Traditional Cardiovascular Risk Factors with Venous Thromboembolism: An Individual Participant Data Meta-analysis of Prospective Studies.
    Circulation. 2016 Nov 9. pii: CIRCULATIONAHA.116.024507.
    PubMed     Abstract available


  47. DE FERRANTI S, Sheldrick RC, Wong JB
    Response by de Ferranti et al to Letter Regarding Article, "Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)".
    Circulation. 2016;134:e395-e396.
    PubMed    


  48. PEREZ DE ISLA L, Saltijeral Cerezo A, Mata P
    Letter by Perez de Isla et al Regarding Article, "Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)".
    Circulation. 2016;134:e393-e394.
    PubMed    


    October 2016
  49. BOZKURT B, Aguilar D, Deswal A, Dunbar SB, et al
    Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Oct 31. pii: CIR.0000000000000450.
    PubMed    


  50. SYME C, Czajkowski S, Shin J, Abrahamowicz M, et al
    Glycerophosphocholine Metabolites and Cardiovascular Disease Risk Factors in Adolescents: A Cohort Study.
    Circulation. 2016 Oct 18. pii: CIRCULATIONAHA.116.022993.
    PubMed     Abstract available


    September 2016
  51. RAGHUVEER G, White DA, Hayman LL, Woo JG, et al
    Cardiovascular Consequences of Childhood Secondhand Tobacco Smoke Exposure: Prevailing Evidence, Burden, and Racial and Socioeconomic Disparities: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Sep 12. pii: CIR.0000000000000443.
    PubMed     Abstract available


  52. HOVINGH GK, Kastelein JJ
    Diagnosis and Management of Individuals With Heterozygous Familial Hypercholesterolemia: Too Late and Too Little.
    Circulation. 2016;134:710-2.
    PubMed    


    August 2016
  53. VOS MB, Kaar JL, Welsh JA, Van Horn LV, et al
    Added Sugars and Cardiovascular Disease Risk in Children: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Aug 22. pii: CIR.0000000000000439.
    PubMed     Abstract available


    July 2016
  54. NANCHEN D, Gencer B, Muller O, Auer R, et al
    Prognosis of Patients with Familial Hypercholesterolemia After Acute Coronary Syndromes.
    Circulation. 2016 Jul 26. pii: CIRCULATIONAHA.116.023007.
    PubMed     Abstract available


  55. CHOMISTEK AK, Henschel B, Eliassen AH, Mukamal KJ, et al
    Frequency, Type, and Volume of Leisure-Time Physical Activity and Risk of Coronary Heart Disease in Young Women.
    Circulation. 2016;134:290-9.
    PubMed     Abstract available


  56. PATON DM
    Letter by Paton Regarding Article, "Knowing the Prevalence of Familial Hypercholesterolemia Matters".
    Circulation. 2016;134:e17-8.
    PubMed    


  57. HAAS ME, Levenson AE, Sun X, Liao WH, et al
    The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated Hypercholesterolemia.
    Circulation. 2016;134:61-72.
    PubMed     Abstract available


  58. RODRIGUEZ F, Knowles JW
    Enough Evidence, Time to Act!
    Circulation. 2016;134:20-3.
    PubMed    


  59. PERAK AM, Ning H, de Ferranti SD, Gooding HC, et al
    Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype.
    Circulation. 2016;134:9-19.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: